Key result
Pretreatment of the paraventricular nucleus region with omega conotoxin largely attenuated the mean circulatory filling pressure and mean arterial pressure responses to pericardial bradykinin injection.
Why the study?
Effector systems modulating venous function remain incompletely understood, prompting investigation into whether the hypothalamic paraventricular nucleus mediates venoconstriction from pericardial bradykinin afferent activation.
The hypothalamic paraventricular nucleus is involved in the venoconstrictor responses to pericardial bradykinin injection, highlighting its role in central control of venous tone.
Answers are grounded in this paper and cite their sources.
Suggests pericardial afferents modulate venous tone; hypothesis-generating for PVN involvement pending translational studies.
Veins are important in the control of venous return, cardiac output, and cardiovascular homeostasis. However, the effector systems modulating venous function remain to be fully elucidated. We demonstrated that activation of bradykinin-sensitive pericardial afferents elicited systemic venoconstriction. The hypothalamic paraventricular nucleus (PVN) is an important site modulating autonomic outflow to the venous compartment. We tested the hypothesis that the PVN region is involved in the venoconstrictor response to pericardial injection of bradykinin. Rats were anesthetized with urethane/alpha chloralose and instrumented for recording arterial pressure, vena caval pressure, and mean circulatory filling pressure (MCFP), an index of venous tone. The rats were fitted with a pericardial catheter and PVN injector guide tubes. Mean arterial pressure (MAP), heart rate (HR), and MCFP responses to pericardial injection of bradykinin (1, 10 µg/kg) were recorded before and after PVN injection of omega conotoxin GVIA (200 ng/200 nl). Pericardial injection of saline produced no systematic effects on MAP, HR, or MCFP. In contrast, pericardial injection of bradykinin was associated with short latency increases in MAP (16 ± 4 to 18 ± 2 mm Hg) and MCFP 0.35 ± 0.19 to 1.01 ± 0.27 mm Hg. Heart rate responses to pericardial BK were highly variable, but HR was significantly increased (15 ± 9 bpm) at the higher BK dose. Conotoxin injection in the PVN region did not affect baseline values for these variables. However, injection of conotoxin into the area of the PVN largely attenuated the pressor (-1 ± 3 to 6 ± 3 mm Hg), MCFP (-0.19 ± 0.07 to 0.20 ± 0.18 mm Hg), and HR (4 ± 14 bpm) responses to pericardial bradykinin injection. We conclude that the PVN region is involved in the venoconstrictor responses to pericardial bradykinin injection.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2022) studied Normal physiology (venous tone regulation). Omega conotoxin GVIA injection into the PVN vs. Vehicle injection was evaluated on Change in mean circulatory filling pressure (MCFP) in response to 10 µg/kg pericardial bradykinin (p=<0.05). Pretreatment of the paraventricular nucleus region with omega conotoxin largely attenuated the mean circulatory filling pressure and mean arterial pressure responses to pericardial bradykinin injection.
Synapse has enriched 10 related papers. Consider them for comparative context: